Combination Chemotherapy and Immunotherapy for Advanced NSCLC
Experts review data updates on chemotherapy / immunotherapy combination treatments in advanced NSCLC.
Source: onclive.com
Stay updated with breaking news from Pd L1 Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts review data updates on chemotherapy / immunotherapy combination treatments in advanced NSCLC.
Closing their discussion, the panel shares their final thoughts on recent updates in advanced NSCLC and looks to the future of treatment.
The panel discusses how patients with advanced NSCLC are sub-grouped in NSCLC and how to approach treatment for each group.
Marina Garassino, MD, reviews the role of PD-L1 testing in advanced non-small cell lung cancer.